Differentiation-stage specific self-peptides bound by major histocompatibility complex class I molecules.
We have tested the hypothesis that phenotypic changes of development are accompanied by expression of differentiation-stage specific peptides bound to major histocompatibility complex (MHC) class I molecules. The U937 cell line, when cultured in the presence of phorbol myristate acetate (PMA), undergoes differentiation from monoblasts to macrophage-like cells. The high-performance liquid chromatography profile of peptides eluted from purified human histocompatibility leukocyte antigen class I molecules expressed by U937 treated with PMA differs from that obtained from control, untreated U937 cells. Chemical sequencing of eluted peptides identified a peptide derived from cytomegalovirus in both treated and untreated cells. PMA-treated, but not untreated cells, displayed an additional peptide derived from interleukin 1 beta. Hence, differentiation-induction of U937 is accompanied by the presentation of at least one differentiation-stage specific peptide. Our results indicate that, similar to viral infection, cellular development and transformation is accompanied by the de novo synthesis of proteins which are processed and presented on MHC class I molecules.
Harris
P E
PE
College of Physicians and Surgeons of Columbia University, Department of Pathology, New York 10032.
Lupu
F
F
Hong
B
B
Reed
E F
EF
Suciu-Foca
N
N
D000595:Amino Acid Sequence; D002454:Cell Differentiation; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D002851:Chromatography, High Pressure Liquid; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D015395:Histocompatibility Antigens Class I / Q000378:metabolism*; D006801:Humans; D007951:Leukemia, Myeloid / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D008285:Major Histocompatibility Complex / Q000276:immunology*; D008969:Molecular Sequence Data; D010455:Peptides / Q000032:analysis / Q000378:metabolism*; D010641:Phenotype; D011233:Precipitin Tests; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D015395:Histocompatibility Antigens Class I; D010455:Peptides; D013755:Tetradecanoylphorbol Acetate